Drug Policy

PPL projects a muted FY26 due to global headwinds but aims to double its India consumer health business turnover to Rs 2,000 crore by FY30 through scale and expansion

Despite NDMA-related cancer concerns and global withdrawals, Indian drug regulators have opted not to suspend Ranitidine, pending further safety review and investigation by a larger expert committee

Trump also didn't commit to pushing Congress to water down a drug pricing programme enacted under President Joe Biden that the pharmaceutical industry has been seeking relief from

The Supreme Court on Monday expressed concern over the illicit drugs trade substance abuse in the country and said there was a need to rehabilitate the youngsters affected instead of demonising them. A bench of Justice BV Nagarathna and Justice N Kotiswar Singh said drug abuse should not be considered a taboo but an open discussion was required to tackle the issue. "We note our disquiet regarding substance abuse in India. Profits are being used to support terrorism and leading to violence. Academic pressure and family disturbances are also leading to the same, which is leading to long-term social and economic instability. Peer pressure, stress from academics and easy availability of drugs is a trigger and adolescents are also using it as emotional escapism," the bench said. "The youth must not follow those who resort to drug abuse and victims of substance abuse are not only limited to the downtrodden but cuts across economic barriers. We need not demonise the ones who have resorted

Earlier, in a bid to tackle the growing problem of drug abuse, LG Saxena announced the launch of a one-month anti-drug campaign set to begin on December 1

Child trafficking, child labour and exploitation by criminals often result in poor mental and physical health of children, leading to high risk of drugs and alcohol abuse

In just the first four months of this year, 41 pilots and cabin crew showed traces of alcohol, of which nine were pilots. In all of 2021, some 59 tested positive, 19 wer pilots

G N Singh, Drug Controller General of India, was speaking at US-India Healthcare Summit in Boston

Drug policy reforms are long overdue

The chemical and fertilizers minister said govt decided against a bulk drug policy